FLUIDDA nv
Quick facts
Marketed products
- Placebo of Roflumilast
This is a placebo formulation with no active pharmacological mechanism.
Phase 3 pipeline
- Placebo of Reference product
A placebo formulation designed to match the physical and sensory characteristics of a reference product for blinded clinical trial comparison. - Placebo of Test product
A placebo control product designed to match the appearance and administration route of FLUIDDA's test product for blinded clinical comparison. - Seretide Evohaler · Respiratory
Seretide Evohaler is a combination of fluticasone and salmeterol, which work together to reduce inflammation and bronchospasm in the airways.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: